Metabolic syndrome is characterized by high levels of inflammatory cytokines [42] and leptin [43] which can promote breast cancer cell growth through various mechanisms [44, 45], and decreased levels of adiponectin [46], resulting in lack of downregulation of tumour cell proliferation and inhibition of apoptosis [45]. This evidence concerns the gene ADIPOQ and neoplasm.